Engineered chiral dyads enhance circularly polarized luminescence in biological systems, indicating new bioimaging possibilities.
The utility of lanthanide-based circularly polarized luminescence (CPL) probes in biological systems is frequently limited by kinetic lability and excitation-related toxicity. To overcome these barriers, we have engineered rigid chiral Ir(III)-Eu(III) dyads (Ir-Eu-R and Ir-Eu-S) using a stereoselective ″complex-as-ligand″ strategy. This architecture features a kinetically inert DO3A macrocycle (1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid) that effectively preserves the stereochemical environment, yielding intense CPL (|glum| = 0.12) with substantial brightness (BCPL ≈ 8 M⁻¹ cm⁻¹). Simultaneously, the integrated Ir(III) antenna enables benign visible-light sensitization (λex = 425 nm), facilitating low-phototoxicity confocal imaging in HeLa cells. Crucially, the probe's structural rigidity ensures exceptional stability against biological interferents; spectroscopic titration with ct-DNA confirms the preservation of chiroptical signals without conformational distortion. This work presents a general coordination strategy for constructing robust, bright, and visible-light-excitable rare-earth chiroptical materials, opening new avenues for specific chiroptical bioimaging and enantioselective sensing applications.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: